A follow-up study of the prevalence of valvular heart abnormalities in hyperprolactinemic patients treated with cabergoline

COUNTER-compliant statistics provided by IRUS-UK.
Unless otherwise indicated, items in Spiral are protected by copyright and are licensed under a Creative Commons Attribution NonCommercial NoDerivatives License.